Target type: biologicalprocess
The process in which a B cell acquires the specialized features of a plasma cell. A plasma cell is a lymphocyte which develops from a B cell and produces high amounts of antibody. [GOC:jal]
Plasma cell differentiation is a complex process that starts with the activation of mature B lymphocytes by antigen. This activation triggers a cascade of events that leads to the differentiation of B cells into antibody-secreting plasma cells. Here is a step-by-step breakdown of the process:
1. **Antigen Recognition and Activation:** Mature B lymphocytes express unique B cell receptors (BCRs) on their surface that can bind to specific antigens. When a B cell encounters its cognate antigen, it internalizes and processes the antigen. The processed antigen is then presented on the surface of the B cell in complex with MHC II molecules.
2. **T cell Collaboration:** The antigen-presenting B cell interacts with a helper T cell (TH cell) that recognizes the antigen presented by the B cell. This interaction leads to the activation of the TH cell and the production of cytokines such as IL-4, IL-5, and IL-6.
3. **B cell Proliferation and Differentiation:** The activated B cell proliferates, giving rise to a clone of B cells. The cytokines produced by the TH cell, along with other signals, induce these B cells to differentiate into plasma cells.
4. **Plasma Cell Formation:** Plasma cells are characterized by a distinct morphology, including a large amount of cytoplasm and a prominent Golgi apparatus. They also express high levels of BCR and are specialized for antibody production.
5. **Antibody Production:** The activated plasma cells produce and secrete large quantities of antibodies. These antibodies are specific for the antigen that initially activated the B cell. Antibodies bind to and neutralize the antigen, thus helping to clear the infection or disease.
6. **Memory Cell Formation:** During the differentiation process, some activated B cells differentiate into memory B cells. These cells persist in the body for long periods and provide long-term immunity against the specific antigen.
The differentiation of B cells into plasma cells is essential for the adaptive immune response. Plasma cells are the primary source of antibodies, which are crucial for defending the body against a wide range of pathogens. The process of plasma cell differentiation involves complex signaling pathways, gene expression changes, and cellular remodeling. This intricate process ensures the efficient generation of antibody-producing cells that are essential for immune protection.'
"
Protein | Definition | Taxonomy |
---|---|---|
B-cell lymphoma 6 protein | A B-cell lymphoma 6 protein that is encoded in the genome of human. [PRO:CNA, UniProtKB:P41182] | Homo sapiens (human) |
Galectin-1 | A galectin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P09382] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
amanozine | diamino-1,3,5-triazine | ||
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactose | alpha-D-galactoside : Any D-galactoside having alpha-configuration at its anomeric centre. | D-galactopyranose | mouse metabolite |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal | |
rifamycin sv | rifamycin SV : A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. rifamycin SV: RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009 | acetate ester; cyclic ketal; lactam; macrocycle; organic heterotetracyclic compound; polyphenol; rifamycins | antimicrobial agent; antitubercular agent; bacterial metabolite |
allolactose | glycosylglucose | Escherichia coli metabolite | |
pf-2545920 | |||
pf-562,271 | indoles |